Welcome to ECVERY
2-Bromo-2-(2-fluorophenyl)-1-cyclopropylethanone
2-Bromo-2-(2-fluorophenyl)-1-cyclopropylethanone
Supplier Info
[China Supplier]
Contact Person : Ms. Yan Li
Tel : 86-512-88169812
Fax : 86-512-88169811
Product Detail
Prasugrel (marketing name Effient in the US, Efient in the EU and Prasita in India) is a novel platelet inhibitor.

Prasugrel (marketing name Effient in the US, Efient in the EU and Prasita in India) is a novel platelet inhibitor developed by Daiichi Sankyo Co. and produced by Ube and currently marketed in the United States in cooperation with Eli Lilly and Company for acute coronary syndromes planned for percutaneous coronary intervention (PCI). Prasugrel was approved for use in Europe in February 2009, and is currently available in the UK. On July 10, 2009, the US Food and Drug Administration approved the use of prasugrel for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndrome who are to be managed with PCI.

2-Bromo-2-(2-fluorophenyl)-1-cyclopropylethanone

Related Products
Ads by Google

About Us | Contact Us | Help | Terms & Conditions
Hot Products: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9
Copyright Notice @ 2008-2013 ECVERY Limited and/or its subsidiaries and licensors. All rights reserved.